$HYPR
Hyperfine, Inc.

2024 Q3 Form 10-Q Financial Statement

#000095017024125624 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue $3.643M
YoY Change 56.35%
Cost Of Revenue $1.735M
YoY Change 43.86%
Gross Profit $1.908M
YoY Change 69.75%
Gross Profit Margin 52.37%
Selling, General & Admin $7.006M
YoY Change -1.93%
% of Gross Profit 367.19%
Research & Development $5.865M
YoY Change 2.2%
% of Gross Profit 307.39%
Depreciation & Amortization $259.0K
YoY Change -6.83%
% of Gross Profit 13.57%
Operating Expenses $12.87M
YoY Change -0.09%
Operating Profit -$10.96M
YoY Change -6.77%
Interest Expense $585.0K
YoY Change -42.7%
% of Operating Profit
Other Income/Expense, Net $52.00K
YoY Change -373.68%
Pretax Income -$10.33M
YoY Change -4.01%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$10.33M
YoY Change -4.01%
Net Earnings / Revenue -283.45%
Basic Earnings Per Share -$0.14
Diluted Earnings Per Share -$0.14
COMMON SHARES
Basic Shares Outstanding 72.68M
Diluted Shares Outstanding 72.68M

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $45.77M
YoY Change -46.43%
Cash & Equivalents $45.77M
Short-Term Investments
Other Short-Term Assets $2.221M
YoY Change -18.7%
Inventory $7.044M
Prepaid Expenses
Receivables $6.800M
Other Receivables $2.264M
Total Short-Term Assets $64.09M
YoY Change -34.74%
LONG-TERM ASSETS
Property, Plant & Equipment $3.125M
YoY Change -1.04%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.167M
YoY Change 28.15%
Total Long-Term Assets $5.292M
YoY Change 9.14%
TOTAL ASSETS
Total Short-Term Assets $64.09M
Total Long-Term Assets $5.292M
Total Assets $69.39M
YoY Change -32.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.404M
YoY Change 54.63%
Accrued Expenses $6.870M
YoY Change 30.78%
Deferred Revenue $1.413M
YoY Change -2.82%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $9.959M
YoY Change 21.29%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change -100.0%
Total Long-Term Liabilities $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.959M
Total Long-Term Liabilities $0.00
Total Liabilities $11.06M
YoY Change 19.01%
SHAREHOLDERS EQUITY
Retained Earnings -$284.1M
YoY Change 16.88%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $58.32M
YoY Change
Total Liabilities & Shareholders Equity $69.39M
YoY Change -32.68%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income -$10.33M
YoY Change -4.01%
Depreciation, Depletion And Amortization $259.0K
YoY Change -6.83%
Cash From Operating Activities -$8.517M
YoY Change -2.34%
INVESTING ACTIVITIES
Capital Expenditures $159.0K
YoY Change -39.54%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$159.0K
YoY Change -39.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 851.0K
YoY Change 2082.05%
NET CHANGE
Cash From Operating Activities -8.517M
Cash From Investing Activities -159.0K
Cash From Financing Activities 851.0K
Net Change In Cash -7.825M
YoY Change -12.52%
FREE CASH FLOW
Cash From Operating Activities -$8.517M
Capital Expenditures $159.0K
Free Cash Flow -$8.676M
YoY Change -3.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001833769
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3M
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2024Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2024Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://hyperfine.io/20240930#AccruedExpensesAndOtherCurrentLiabilities
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39949
dei Entity Registrant Name
EntityRegistrantName
Hyperfine, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1569027
dei Entity Address Address Line1
EntityAddressAddressLine1
351 New Whitfield Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Guilford
dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06437
dei City Area Code
CityAreaCode
866
dei Local Phone Number
LocalPhoneNumber
796-6767
dei Security12b Title
Security12bTitle
Class A common stock, $0.0001 Par Value Per Share
dei Trading Symbol
TradingSymbol
HYPR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45765000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
75183000
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
219000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
621000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
482000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
321000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6800000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3189000
CY2024Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2264000
CY2023Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
942000
CY2024Q3 us-gaap Inventory Net
InventoryNet
7044000
CY2023Q4 us-gaap Inventory Net
InventoryNet
6582000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2002000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2391000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
64094000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
88908000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3125000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2999000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2167000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2292000
CY2024Q3 us-gaap Assets
Assets
69386000
CY2023Q4 us-gaap Assets
Assets
94199000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1404000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1214000
CY2024Q3 hypr Deferred Grant Funding Current
DeferredGrantFundingCurrent
219000
CY2023Q4 hypr Deferred Grant Funding Current
DeferredGrantFundingCurrent
621000
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1413000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1453000
CY2024Q3 hypr Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
6870000
CY2023Q4 hypr Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
5419000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
9959000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8768000
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1105000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
968000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
64000
CY2024Q3 us-gaap Liabilities
Liabilities
11064000
CY2023Q4 us-gaap Liabilities
Liabilities
9800000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
342367000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
338114000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-284052000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-253722000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
58322000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
84399000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
69386000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
94199000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3643000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2330000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10569000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8346000
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1735000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1206000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5504000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4623000
CY2024Q3 us-gaap Gross Profit
GrossProfit
1908000
CY2023Q3 us-gaap Gross Profit
GrossProfit
1124000
us-gaap Gross Profit
GrossProfit
5065000
us-gaap Gross Profit
GrossProfit
3723000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5865000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5739000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17394000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16531000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4510000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4615000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13361000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16103000
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2496000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2529000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6769000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7575000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
12871000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
12883000
us-gaap Operating Expenses
OperatingExpenses
37524000
us-gaap Operating Expenses
OperatingExpenses
40209000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10963000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11759000
us-gaap Operating Income Loss
OperatingIncomeLoss
-32459000
us-gaap Operating Income Loss
OperatingIncomeLoss
-36486000
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
585000
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1021000
us-gaap Investment Income Interest
InvestmentIncomeInterest
2056000
us-gaap Investment Income Interest
InvestmentIncomeInterest
2920000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
52000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-19000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
73000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10326000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10757000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30330000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-33554000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-10326000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10757000
us-gaap Net Income Loss
NetIncomeLoss
-30330000
us-gaap Net Income Loss
NetIncomeLoss
-33554000
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72678622
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72678622
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71464315
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71464315
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72219681
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72219681
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71178769
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71178769
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
84399000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-9848000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
55000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1032000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
75638000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-10156000
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
105000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1174000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
66761000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-10326000
CY2024Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-1000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1103000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
58322000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
123722000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-12160000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
49000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1126000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
112737000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-10637000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
58000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1133000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
103291000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10757000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
39000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1194000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
93767000
us-gaap Profit Loss
ProfitLoss
-30330000
us-gaap Profit Loss
ProfitLoss
-33554000
us-gaap Depreciation
Depreciation
775000
us-gaap Depreciation
Depreciation
791000
us-gaap Share Based Compensation
ShareBasedCompensation
3308000
us-gaap Share Based Compensation
ShareBasedCompensation
3453000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-156000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-48000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
6000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
25000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3611000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
334000
hypr Unbilled Receivables
UnbilledReceivables
1322000
hypr Unbilled Receivables
UnbilledReceivables
228000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
579000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2494000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
324000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1010000
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-48000
us-gaap Increase Decrease In Prepaid Supplies
IncreaseDecreaseInPrepaidSupplies
-693000
us-gaap Increase Decrease In Prepaid Supplies
IncreaseDecreaseInPrepaidSupplies
-281000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
9000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-142000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
193000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
229000
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-402000
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-196000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
97000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-364000
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-8000
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
48000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
949000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-776000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30410000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31871000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
375000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
546000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-375000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-546000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
160000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
146000
hypr Proceeds From Shares Issued Under At The Market Offering Program Net Of Selling Costs
ProceedsFromSharesIssuedUnderAtTheMarketOfferingProgramNetOfSellingCosts
805000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
965000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
146000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-29820000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-32271000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75804000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118243000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45984000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
85972000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45765000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85424000
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
219000
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
548000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45984000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
85972000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
571000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
54000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentrations of Credit Risk</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company's cash and cash equivalents are deposited with several major financial institutions. At times, deposits in these institutions exceed the amount of insurance provided on such deposits. The Company reduces this risk by maintaining such deposits with high quality financial institutions that management believes are creditworthy and the Company monitors this credit risk and makes adjustments to the concentrations as necessary. The Company has not experienced any losses in such accounts and does not believe that it is exposed to any significant risk of loss on these balances.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">With respect to accounts receivable, credit risk is mitigated by the Company’s ongoing credit evaluation of its customers’ financial condition. As of September 30, 2024 and December 31, 2023, the Company had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">two</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> customers and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">four</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> customers, respectively, that each accounted for more than 10% of trade receivables. With respect to revenue, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">two</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> customers each accounted for more than 10% of revenue for the three and nine months ended September 30, 2024, respectively. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">Two</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> customers each accounted for more than 10% of revenue for each of the three and nine months ended September 30, 2023.</span></p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions about future events that affect the amounts reported in its condensed consolidated financial statements and accompanying notes. Future events and their effects cannot be determined with certainty. On an ongoing basis, management evaluates these estimates and assumptions. Significant estimates and assumptions included:</span></p><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:6.983857620229827%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Revenue recognition, including determination of the timing and pattern of satisfaction of performance obligations, determination of the standalone selling price (“SSP”) of performance obligations;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:6.983857620229827%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Allowance for credit losses;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:6.983857620229827%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net realizable value (the selling price as well as estimated costs of disposal and transportation) of inventory, and demand and future use of inventory;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:6.983857620229827%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Valuation allowances with respect to deferred tax assets; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:6.983857620229827%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Assumptions underlying the fair value used in the calculation of stock-based compensation expense.</span></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company bases these estimates on historical and anticipated results and trends and on various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates, and any such differences may be material to the Company’s condensed </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">consolidated financial statements.</span></p>
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3643000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2330000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10569000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8346000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6800000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3189000
CY2024Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2264000
CY2023Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
942000
CY2024Q3 hypr Unbilled Receivables Noncurrent
UnbilledReceivablesNoncurrent
1119000
CY2023Q4 hypr Unbilled Receivables Noncurrent
UnbilledReceivablesNoncurrent
1044000
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1413000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1453000
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1105000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
968000
hypr Revenue Recognize Receivable Payment Terms Range Minimum
RevenueRecognizeReceivablePaymentTermsRangeMinimum
P30D
hypr Revenue Recognize Receivable Payment Terms Range Maximum
RevenueRecognizeReceivablePaymentTermsRangeMaximum
P1Y
CY2024Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
475000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1172000
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
477000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1119000
CY2024Q3 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
480000
CY2023Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
391000
CY2024Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
408000
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
814000
CY2023Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
205000
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
331000
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
5682000
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
5661000
CY2024Q3 hypr Revenue Remaining Performance Obligation Expected Timing Percentage
RevenueRemainingPerformanceObligationExpectedTimingPercentage
0.10
CY2024Q3 hypr Revenue Remaining Performance Obligation Expected Timing Percentage
RevenueRemainingPerformanceObligationExpectedTimingPercentage
0.90
CY2024Q3 hypr Fair Value Assets Transfer Between Levels Amount
FairValueAssetsTransferBetweenLevelsAmount
0
hypr Fair Value Assets Transfer Between Levels Amount
FairValueAssetsTransferBetweenLevelsAmount
0
CY2023Q3 hypr Fair Value Assets Transfer Between Levels Amount
FairValueAssetsTransferBetweenLevelsAmount
0
hypr Fair Value Assets Transfer Between Levels Amount
FairValueAssetsTransferBetweenLevelsAmount
0
CY2024Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
3419000
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1757000
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3625000
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4825000
CY2024Q3 us-gaap Inventory Net
InventoryNet
7044000
CY2023Q4 us-gaap Inventory Net
InventoryNet
6582000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6597000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6038000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3472000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3039000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3125000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2999000
CY2024Q3 us-gaap Depreciation
Depreciation
259000
us-gaap Depreciation
Depreciation
775000
CY2023Q3 us-gaap Depreciation
Depreciation
278000
us-gaap Depreciation
Depreciation
791000
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2025-04-30
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
105000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
113000
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7M
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.079
CY2024Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
45000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
134000
CY2024Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
50000
us-gaap Operating Lease Payments
OperatingLeasePayments
147000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
50000
CY2024Q3 hypr Lessee Operating Lease Liability Payments Due Thereafter
LesseeOperatingLeaseLiabilityPaymentsDueThereafter
66000
CY2024Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2182000
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2463000
CY2024Q3 hypr Accrued Contracted Services Current
AccruedContractedServicesCurrent
2248000
CY2023Q4 hypr Accrued Contracted Services Current
AccruedContractedServicesCurrent
1237000
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
562000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
412000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1117000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
676000
CY2024Q3 hypr Accrued Operating Lease Liabilities Current
AccruedOperatingLeaseLiabilitiesCurrent
113000
CY2023Q4 hypr Accrued Operating Lease Liabilities Current
AccruedOperatingLeaseLiabilitiesCurrent
185000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
648000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
446000
CY2024Q3 hypr Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
6870000
CY2023Q4 hypr Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
5419000
CY2024Q2 hypr Number Of Nonemployee Director
NumberOfNonemployeeDirector
5
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1102000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1194000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3308000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3453000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-10326000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10757000
us-gaap Net Income Loss
NetIncomeLoss
-30330000
us-gaap Net Income Loss
NetIncomeLoss
-33554000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10326000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10757000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-30330000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-33554000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72678622
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72678622
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71464315
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71464315
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72219681
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72219681
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71178769
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71178769
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
28296081
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
24698585
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
28296081
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
24698585
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2024Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2024Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2021Q4 hypr Deferred Grant Funding Current
DeferredGrantFundingCurrent
4910000
CY2020Q4 hypr Deferred Grant Funding Current
DeferredGrantFundingCurrent
4910000
CY2021 hypr Number Of Swoop System And Other Services Deployed
NumberOfSwoopSystemAndOtherServicesDeployed
25
CY2023Q2 hypr Grant Awarded
GrantAwarded
3354000
CY2024Q3 hypr Grant Deliverables And Milestones Amount
GrantDeliverablesAndMilestonesAmount
1482000
CY2024Q3 us-gaap Grants Receivable Current
GrantsReceivableCurrent
1122000
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
219000
CY2024Q3 hypr Grant Fund Required To Return Under Provisions
GrantFundRequiredToReturnUnderProvisions
0
CY2023Q4 hypr Grant Fund Required To Return Under Provisions
GrantFundRequiredToReturnUnderProvisions
0
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
1000000
CY2024Q3 hypr Earn Out Liability
EarnOutLiability
0
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 hypr Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
CY2024Q3 hypr Non Rule10 B51 Arr Modified Flag
NonRule10B51ArrModifiedFlag
false
hypr Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
hypr Non Rule10 B51 Arr Modified Flag
NonRule10B51ArrModifiedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-125624-index-headers.html Edgar Link pending
0000950170-24-125624-index.html Edgar Link pending
0000950170-24-125624.txt Edgar Link pending
0000950170-24-125624-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hypr-20240930.htm Edgar Link pending
hypr-20240930.xsd Edgar Link pending
hypr-ex31_1.htm Edgar Link pending
hypr-ex31_2.htm Edgar Link pending
hypr-ex32.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
hypr-20240930_htm.xml Edgar Link completed
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable